Through the analysis results based on CellMiner data, 19 types of 57 drugs approved by the American Food and Drug Administration or verified by clinical trials may benefit cancer patients with high-SKP2 expression, as cancer cells with upregulated SKP2 expression were susceptible to these drugs based on the results of IC50 (p < 0.05) (Fig. 10). Here, SKP2 is linked to cancer.